ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,035Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 1121

$808K Total Retail Price of All Prescriptions

Rank: 142 out of 1121

610 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 610 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 13,719 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LEVOTHYROXINE SODIUM 895 719 1 2
SIMVASTATIN 742 488 2 1
METFORMIN HCL 733 564 3 8
OMEPRAZOLE 593 390 4 6
HYDROCODONE-ACETAMINOPHEN 575 346 S3 5 3
LOVASTATIN 488 367 6 26
LISINOPRIL 473 354 7 4
AMLODIPINE BESYLATE 461 373 8 5
FUROSEMIDE 401 320 9 7
GLIMEPIRIDE 369 280 10 34
PRAVASTATIN SODIUM 347 277 11 14
METOPROLOL TARTRATE 327 222 12 9
HYDROCHLOROTHIAZIDE 324 249 13 10
GABAPENTIN 318 225 14 13
POTASSIUM CHLORIDE 303 264 15 12
ZOLPIDEM TARTRATE 296 208 16 19
ATORVASTATIN CALCIUM 272 182 17 15
ATENOLOL 258 209 18 16
CITALOPRAM HBR 257 172 19 18
RANITIDINE HCL 232 142 20 33
WARFARIN SODIUM 213 186 21 11
FLUOXETINE HCL 205 140 22 60
FENOFIBRATE 196 120 23 71
MELOXICAM 194 141 24 22
TAMSULOSIN HCL 189 161 25 32
KLOR-CON 10 189 124 25 69
TRAMADOL HCL 187 157 27 25
NEXIUM 181 71 28 24
JANUVIA 177 134 29 81
LOSARTAN POTASSIUM 156 149 30 17
AZITHROMYCIN 150 101 31 44
CLONIDINE HCL 145 116 32 39
AMITRIPTYLINE HCL 141 98 R 33 61
CLOPIDOGREL 136 110 34 27
PROAIR HFA 129 87 35 48
CIPROFLOXACIN HCL 125 95 36 57
ESTRADIOL 125 36 R 36 95
TIZANIDINE HCL 123 73 38 124
ENALAPRIL MALEATE 120 89 39 73
LISINOPRIL-HYDROCHLOROTHIAZIDE 119 96 40 31
AMLODIPINE BESYLATE-BENAZEPRIL 118 101 41 65
TRAZODONE HCL 115 72 42 40
DONEPEZIL HCL 109 100 43 35
BENAZEPRIL HCL 109 88 43 41
ALLOPURINOL 105 92 45 30
SERTRALINE HCL 105 84 45 21
PLAVIX 105 88 45 42
ALENDRONATE SODIUM 104 92 48 37
FINASTERIDE 98 39 49 117
CRESTOR 96 44 50 28
PANTOPRAZOLE SODIUM 94 81 51 29
PAROXETINE HCL 92 73 52 58
SINGULAIR 89 54 53 78
VERAPAMIL ER 86 55 54 89
GEMFIBROZIL 86 41 54 88
GLYBURIDE 85 68 R 56 51
AMOXICILLIN 82 57 57 140
COMBIVENT 81 59 58 129
FLUTICASONE PROPIONATE 80 32 59 36
SPIRONOLACTONE 79 17 60 54
LIPITOR 78 68 61 106
METOPROLOL SUCCINATE 76 61 62 23
CARVEDILOL 74 54 63 20
HYDRALAZINE HCL 73 65 64 66
OXYBUTYNIN CHLORIDE 72 55 65 128
MECLIZINE HCL 72 45 65 115
SPIRIVA 69 53 67 49
DILTIAZEM 24HR ER 68 56 68 172
NIFEDIPINE ER 66 54 69 102
DIOVAN HCT 64 26 70 90
PROPRANOLOL HCL 63 50 71 123
BUSPIRONE HCL 61 30 72 114
LOSARTAN-HYDROCHLOROTHIAZIDE 59 49 73 46
NATEGLINIDE 57 41 74 246
TRIAMTERENE-HCTZ 57 44 74 38
AMOX TR-POTASSIUM CLAVULANATE 57 39 74 101
CEPHALEXIN 56 43 77 111
DIOVAN 54 30 78 45
DOXAZOSIN MESYLATE 53 49 79 93
IBUPROFEN 52 25 80 110
CYCLOBENZAPRINE HCL 51 17 R 81 83
BACLOFEN 51 35 81 131
QUETIAPINE FUMARATE 51 36 81 75
ISOSORBIDE MONONITRATE ER 50 48 84 62
ESCITALOPRAM OXALATE 50 27 84 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.